Skip to main content
Reimbursement strategy

Cost-effective market access strategy for medical technologies in Europe

A holistic approach to reimbursement strategies trusted by global market leaders and SMEs

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Rapid HTAs of two medical devices released in Tuscany

23 Jun 2023

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 11957 of June 07, 2023, Tuscany Regional Healthcare has published assessments of two medical devices in the cardiovascular and spine areas.

The following technologies have been assessed:

  • Cobalt-chrome external stent Vest 2.0 by Vascular Graft Solution for patients undergoing a coronary artery bypass graft procedure for the treatment of severe arteriosclerotic coronary artery disease;
  • Removable percutaneous interspinous fusion device QFusion by Techlamed for patients affected by neurogenic claudication due to symptomatic stenosis of the vertebral canal associated with instability and who are not candidates for open surgery due to contraindications or comorbidities.

See the regional decree and all assessments in Italian here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Contact us to get a free, three-month, no-obligation trial.